Body Mass Index as a Major Prognostic Contributing Factor in COVID-19: A Multicentral Egyptian Study
暂无分享,去创建一个
Marwa Salah Mahmoud | Usama M. Abdelaal | Hytham Abdalla | Mohamed Ramadan Izzaldin | Mohammed Tag-Adeen | Hossam Abd El-Moez Mohammed | Mohammed H Hassan | Amira Maher | Mohamed Malak | Sara Adel | Wael Esmat Ali | Alyaa Abo-Rahma | Mona Gouda Maghrabi Abd Elnabi | Ibrahim Ahmed Mosa Abdalla | Mohamed Fakhry Mohamed Morsy | Mohamed Abdel Fattah Mohamed Sayed
[1] Shimaa A. Mahmoud,et al. Outcome of Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19) patients , 2023, SVU-International Journal of Medical Sciences.
[2] M. Abdelmotaleb. Spontaneous pneumothorax and spontaneous pneumomediastinum in COVID-19 patients. , 2022, SVU-International Journal of Medical Sciences.
[3] Aline Duarte de Souza,et al. Avaliação do risco e estado nutricional em pacientes com Covid-19 hospitalizados , 2022, DEMETRA: Alimentação, Nutrição & Saúde.
[4] C. F. Leochico,et al. Body mass index and its association with COVID-19 clinical outcomes: Findings from the Philippine CORONA study , 2022, Clinical Nutrition ESPEN.
[5] M. Schaalan,et al. The Impact of Sociodemographic, Nutritional, and Health Factors on the Incidence and Complications of COVID-19 in Egypt: A Cross-Sectional Study , 2022, Viruses.
[6] Feng Pan,et al. The association of obesity with the progression and outcome of COVID‐19: The insight from an artificial‐intelligence‐based imaging quantitative analysis on computed tomography , 2022, Diabetes/metabolism research and reviews.
[7] Andinet B Gizaw,et al. Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis , 2022, BMJ nutrition, prevention & health.
[8] Lei Zhao,et al. Both Underweight and Obesity Are Associated With an Increased Risk of Coronavirus Disease 2019 (COVID-19) Severity , 2021, Frontiers in Nutrition.
[9] E. Ciolac,et al. Determinants of endothelial dysfunction in noncritically ill hospitalized COVID‐19 patients: A cross‐sectional study , 2021, Obesity.
[10] E. Abdelilah,et al. Lymphopenia in Covid-19: A single center retrospective study of 589 cases , 2021, Annals of Medicine and Surgery.
[11] A. Dosanjh,et al. The risk of pressure ulcers in a proned COVID population , 2021, The Surgeon.
[12] N. Desai,et al. Association of obesity with venous thromboembolism and myocardial injury in COVID-19 , 2021, Obesity Research & Clinical Practice.
[13] J. Bonventre,et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection , 2021, Nature Metabolism.
[14] S. O’Rahilly,et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study , 2021, The Lancet Diabetes & Endocrinology.
[15] J. Gameiro,et al. The Weight of Obesity in Immunity from Influenza to COVID-19 , 2021, Frontiers in Cellular and Infection Microbiology.
[16] H. Abdelkhalek,et al. Neurological Diseases: Cause and Effect in the Era of COVID-19 , 2021, SVU-International Journal of Medical Sciences.
[17] H. H. Chiu,et al. The prevalence of malnutrition and analysis of related factors among adult patients with the Coronavirus Disease 2019 (COVID 19) in a tertiary government hospital: The MalnutriCoV study , 2021, Clinical Nutrition ESPEN.
[18] H. Jia,et al. High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study , 2021, BMC Infectious Diseases.
[19] M. Jaeger,et al. A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients , 2021, International Journal of Obesity.
[20] Amal Fathi Gharib,et al. Impact of Obesity and Its Associated Comorbid Conditions on COVID-19 Presentation , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.
[21] Y. Hu,et al. [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[22] G. Ahmed. Managing Diabetic Patients during the Coronavirus Disease (COVID-19) Pandemic , 2020 .
[23] H. Dupont,et al. The association between body mass index class and coronavirus disease 2019 outcomes , 2020, International Journal of Obesity.
[24] A. Hamdy,et al. A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic , 2020, Frontiers in Endocrinology.
[25] J. Hirsch,et al. BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID‐19 in New York , 2020, Obesity.
[26] Gang Wu,et al. The importance of overweight in COVID-19 , 2020, Medicine.
[27] C. Ayers,et al. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. , 2020, Circulation.
[28] W. Ji,et al. Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: A matter of sexual dimorphism? , 2020, Diabetes Research and Clinical Practice.
[29] B. Charra,et al. Nutritional status assessment in patients with Covid-19 after discharge from the intensive care unit , 2020, Clinical Nutrition ESPEN.
[30] H. Namkoong,et al. Susceptibility of the obese population to COVID-19 , 2020, International Journal of Infectious Diseases.
[31] N. Soetedjo,et al. Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[32] P. Huang,et al. Obese COVID‐19 patients show more severe pneumonia lesions on CT chest imaging , 2020, Diabetes, obesity & metabolism.
[33] A. Hussein,et al. Is there a correlation between pulmonary inflammation index with COVID-19 disease severity and outcome? , 2020, medRxiv.
[34] S. Czernichow,et al. Obesity Doubles Mortality in Patients Hospitalized for Severe Acute Respiratory Syndrome Coronavirus 2 in Paris Hospitals, France: A Cohort Study on 5,795 Patients , 2020, Obesity.
[35] Juping Yuan,et al. Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics , 2020, International journal of molecular sciences.
[36] P. Hegyi,et al. Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[37] Z. Xia,et al. Obesity and mortality of COVID-19. Meta-analysis , 2020, Obesity Research & Clinical Practice.
[38] M. Berger. Nutrition Status Affects COVID‐19 Patient Outcomes , 2020, JPEN. Journal of parenteral and enteral nutrition.
[39] S. Al-Youha,et al. Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait , 2020, EClinicalMedicine.
[40] A. Mohamed,et al. Characteristics, Outcomes and Indicators of Severity for COVID-19 Among Sample of ESNA Quarantine Hospital’s Patients, Egypt: A Retrospective Study , 2020, Infection and drug resistance.
[41] M. Aly,et al. Indicators of Critical Illness and Predictors of Mortality in COVID-19 Patients , 2020, Infection and drug resistance.
[42] C. Yanover,et al. What Factors Increase the Risk of Complications in SARS-CoV-2–Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization , 2020, JMIR public health and surveillance.
[43] S. Hadjadj,et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study , 2020, Diabetologia.
[44] R. Vettor,et al. Obesity and COVID‐19: An Italian Snapshot , 2020, Obesity.
[45] P. Vanhems,et al. Prevalence of obesity among adult inpatients with COVID-19 in France , 2020, The Lancet Diabetes & Endocrinology.
[46] Feng Gao,et al. Obesity Is a Risk Factor for Greater COVID-19 Severity , 2020, Diabetes Care.
[47] C. Mantzoros,et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York , 2020, Metabolism.
[48] R. Arena,et al. Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation , 2020, The American Journal of Medicine.
[49] Norbert Stefan,et al. Obesity and impaired metabolic health in patients with COVID-19 , 2020, Nature Reviews Endocrinology.
[50] Tao Li,et al. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China , 2020, European Journal of Clinical Nutrition.
[51] Iain B McInnes,et al. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. , 2020, Circulation.
[52] R. José,et al. Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome? , 2020, Obesity.
[53] D. Mathieu,et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation , 2020, Obesity.
[54] Lei Liu,et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China , 2020, Diabetes Care.
[55] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[56] Wei Xu,et al. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[57] Wei Wang,et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.
[58] Heshui Shi,et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.
[59] C. Zheng,et al. Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia , 2020, Radiology.
[60] C. Zheng,et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19) , 2020 .
[61] L. Forni,et al. Lung–kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup , 2019, Intensive Care Medicine.
[62] S. Schultz-Cherry,et al. Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution , 2019, Front. Immunol..
[63] J. S. Lima Rodríguez,et al. Risk factors for pressure ulcer development in Intensive Care Units: A systematic review. , 2017, Medicina intensiva.
[64] Joshua A. Salomon,et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.
[65] Cheryl Newton,et al. Body mass index and pressure ulcers: improved predictability of pressure ulcers in intensive care patients. , 2014, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[66] M. Elia,et al. ESPEN guidelines for nutrition screening 2002. , 2003, Clinical nutrition.
[67] THE WORLD HEALTH ORGANIZATION , 1954 .
[68] M. El-Dahshan,et al. OUTCOMES OF COVID-19 IN EGYPTIAN PATIENTS , 2021, Al-Azhar Medical Journal.
[69] C. Guérin,et al. The impact of patient positioning on pressure ulcers in patients with severe ARDS: results from a multicentre randomised controlled trial on prone positioning , 2013, Intensive Care Medicine.
[70] M. Kone,et al. Infection and Drug Resistance , 2022 .